Logo image of RFL

RAFAEL HOLDINGS INC-CLASS B (RFL) Stock Fundamental Analysis

USA - NYSE:RFL - US75062E1064 - Common Stock

1.36 USD
0 (0%)
Last: 9/26/2025, 8:04:00 PM
1.35 USD
-0.01 (-0.74%)
After Hours: 9/26/2025, 8:04:00 PM
Fundamental Rating

2

Overall RFL gets a fundamental rating of 2 out of 10. We evaluated RFL against 196 industry peers in the Pharmaceuticals industry. The financial health of RFL is average, but there are quite some concerns on its profitability. RFL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

RFL had negative earnings in the past year.
In the past year RFL has reported a negative cash flow from operations.
RFL had negative earnings in each of the past 5 years.
RFL had a negative operating cash flow in each of the past 5 years.
RFL Yearly Net Income VS EBIT VS OCF VS FCFRFL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -21.18%, RFL is in line with its industry, outperforming 59.69% of the companies in the same industry.
RFL has a Return On Equity of -28.41%. This is in the better half of the industry: RFL outperforms 60.71% of its industry peers.
Industry RankSector Rank
ROA -21.18%
ROE -28.41%
ROIC N/A
ROA(3y)-47.6%
ROA(5y)-33.28%
ROE(3y)-55.93%
ROE(5y)-39.35%
ROIC(3y)N/A
ROIC(5y)N/A
RFL Yearly ROA, ROE, ROICRFL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

The Gross Margin of RFL (74.86%) is better than 83.16% of its industry peers.
The Profit Margin and Operating Margin are not available for RFL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RFL Yearly Profit, Operating, Gross MarginsRFL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K

More info and screens

4

2. Health

2.1 Basic Checks

RFL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RFL has more shares outstanding
Compared to 5 years ago, RFL has more shares outstanding
Compared to 1 year ago, RFL has a worse debt to assets ratio.
RFL Yearly Shares OutstandingRFL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
RFL Yearly Total Debt VS Total AssetsRFL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

RFL has an Altman-Z score of -1.98. This is a bad value and indicates that RFL is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.98, RFL is in line with its industry, outperforming 46.43% of the companies in the same industry.
RFL has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
RFL has a Debt to Equity ratio of 0.01. This is comparable to the rest of the industry: RFL outperforms 59.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -1.98
ROIC/WACCN/A
WACC9.8%
RFL Yearly LT Debt VS Equity VS FCFRFL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 3.85 indicates that RFL has no problem at all paying its short term obligations.
RFL's Current ratio of 3.85 is fine compared to the rest of the industry. RFL outperforms 62.76% of its industry peers.
RFL has a Quick Ratio of 3.82. This indicates that RFL is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.82, RFL is in the better half of the industry, outperforming 64.29% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.85
Quick Ratio 3.82
RFL Yearly Current Assets VS Current LiabilitesRFL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

RFL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.01%, which is quite impressive.
The Revenue has grown by 35.06% in the past year. This is a very strong growth!
The Revenue for RFL have been decreasing by -33.59% on average. This is quite bad
EPS 1Y (TTM)21.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.96%
Revenue 1Y (TTM)35.06%
Revenue growth 3Y-7.31%
Revenue growth 5Y-33.59%
Sales Q2Q%7.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RFL Yearly Revenue VS EstimatesRFL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RFL. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RFL Price Earnings VS Forward Price EarningsRFL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RFL Per share dataRFL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RFL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RAFAEL HOLDINGS INC-CLASS B

NYSE:RFL (9/26/2025, 8:04:00 PM)

After market: 1.35 -0.01 (-0.74%)

1.36

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)06-17 2025-06-17
Earnings (Next)11-04 2025-11-04
Inst Owners7.7%
Inst Owner Change16.7%
Ins Owners45.18%
Ins Owner Change3.75%
Market Cap47.72M
Analysts0
Price TargetN/A
Short Float %0.31%
Short Ratio0.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 65.19
P/FCF N/A
P/OCF N/A
P/B 0.59
P/tB 2.42
EV/EBITDA N/A
EPS(TTM)-0.94
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)-0.33
OCFYN/A
SpS0.02
BVpS2.3
TBVpS0.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.18%
ROE -28.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.86%
FCFM N/A
ROA(3y)-47.6%
ROA(5y)-33.28%
ROE(3y)-55.93%
ROE(5y)-39.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 16.88%
Cap/Sales 7.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.85
Quick Ratio 3.82
Altman-Z -1.98
F-Score4
WACC9.8%
ROIC/WACCN/A
Cap/Depr(3y)26.37%
Cap/Depr(5y)24.37%
Cap/Sales(3y)9.31%
Cap/Sales(5y)13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.96%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)35.06%
Revenue growth 3Y-7.31%
Revenue growth 5Y-33.59%
Sales Q2Q%7.74%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y83.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.86%
OCF growth 3YN/A
OCF growth 5YN/A